Last July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the therapy.

Automated insulin reduces hypoglycaemia in elderly, enabling safer diabetes management for seniors- read to learn more.

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Hybrid closed-loop insulin delivery lowers risk for hypoglycemic coma and increases rate of ketoacidosis for young people with T1D.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its revolutionary Omnipod 5 ...

The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...